Grantham, Mayo, Van Otterloo & Co (GMO)
HZNP

Grantham, Mayo, Van Otterloo & Co (GMO)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-123,376
Closed -$14.3M – 608
2023
Q3 		$14.3M Sell
123,376
-189,535
-61% -$20.4M 0.07% 222
2023
Q2 		$32.2M Buy
312,911
+97,052
+45% +$10.2M 0.15% 125
2023
Q1 		$23.6M Buy
215,859
+171,563
+387% +$19M 0.12% 166
2022
Q4 		$5.04M Buy
+44,296
New +$3.68M 0.03% 331
2019
Q1 		– Sell
-11,200
Closed -$219K – 764
2018
Q4 		$219K Buy
+11,200
New +$220K ﹤0.01% 506

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return